Hitomi Sakai

1.3k citations

50 papers · 1.0k indexed · h-index 16

Biotechnology top 5%
Drug Discovery top 10%
Molecular Biology
Insect Science top 10%
Pulmonary and Respiratory Medicine
- Neonatal Respiratory Health Research 11
- Respiratory Support and Mechanisms 3
Immunology
- Invertebrate Immune Response Mechanisms 6
- Aquaculture disease management and microbiota 3
Surgery
- Congenital Diaphragmatic Hernia Studies 5
Microbiology
- Antimicrobial Peptides and Activities 3
Epidemiology
- Congenital Heart Disease Studies 3
Obstetrics and Gynecology
- Pregnancy and preeclampsia studies 2

Co-authors: Takeshi Watanabe Kiichiro Kobori K Miyashita M. Uchida Hironori Tanaka Takeshi Fujii Yasuo Oyama Yuji Sakai
Cited by: Biotechnology Drug Discovery Molecular Biology
Journals: Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (2 papers)
Partner nations: Japan United States South Korea

In The Last Decade

Hitomi Sakai

47 papers receiving 977 citations

Peers

Countries citing papers authored by Hitomi Sakai

Since Specialization

Citations

This map shows the geographic impact of Hitomi Sakai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitomi Sakai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitomi Sakai more than expected).

Fields of papers citing papers by Hitomi Sakai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitomi Sakai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitomi Sakai. The network helps show where Hitomi Sakai may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hitomi Sakai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hitomi Sakai Line = papers co-authored together Hitomi Sakai links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Phase Ib trial of tasurgratinib (E7090) with or without endocrine therapies for patients (pts) with ER+, HER2− recurrent/metastatic breast cancer (BC) after receiving a CDK4/6 inhibitor. Journal of Clinical Oncology ·Takahiro Kogawa,Toshinari Yamashita,Takanori Ishida,Kan Yonemori,Hiroji Iwata,Akihiko Shimomura,Kenjiro Aogi,Kenichi Inoue,Toru Mukohara,Takahiro Nakayama,Hitomi Sakai,Shigehisa Kitano,Shingo Kobayashi,Takuya Nakada,Ippei Suzuki,Yohei Otake,Junji Tsurutani	2024	1
2	KRAS Inhibitor Resistance in MET -Amplified KRAS G12C Non–Small Cell Lung Cancer Induced By RAS- and Non–RAS-Mediated Cell Signaling Mechanisms Clinical Cancer Research ·Shinichiro Suzuki,Kimio Yonesaka,Takeshi Teramura,Toshiyuki Takehara,Ryoji Kato,Hitomi Sakai,Koji Haratani,Junko Tanizaki,Hisato Kawakami,Hidetoshi Hayashi,Kazuko Sakai,Kazuto Nishio,Kazuhiko Nakagawa	2021	66
3	How do doctors choose treatment for older gynecological cancer patients? A Japanese Gynecologic Oncology Group survey of gynecologic oncologists International Journal of Clinical Oncology ·Makoto Yamamoto,Yoshio Yoshida,Yoshio Itani,Shinya Sato,Masayuki Futagami,Hitomi Sakai,Hiroaki Kajiyama,Masaki Fujimura,Yoichi Aoki	2019	2
4	HER2 genomic amplification in circulating tumor DNA and estrogen receptor positivity predict primary resistance to trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer Breast Cancer ·Hitomi Sakai,Junji Tsurutani,Tsutomu Iwasa,Yoshifumi Komoike,Kazuko Sakai,Kazuto Nishio,Kazuhiko Nakagawa	2018	46
5	Effect of 4-[(5,6,7,8-Tetrahydro-5,5,8,8-Tetramethyl-2-Naphthalenyl)Carbamoyl]Benzoic Acid (Am80) on Alveolar Regeneration in Adiponectin Deficient-Mice Showing a Chronic Obstructive Pulmonary Disease–Like Pathophysiology Journal of Pharmacology and Experimental Therapeutics ·Hitomi Sakai,Michiko Horiguchi,Tomomi Akita,Chihiro Ozawa,Mai Hirokawa,Yuki Oiso,Harumi Kumagai,Yoshito Takeda,Isao Tachibana,Norikazu Maeda,Chikamasa Yamashita	2017	5
6	Successful osimertinib treatment for leptomeningeal carcinomatosis from lung adenocarcinoma with the T790M mutation of EGFR ESMO Open ·Hitomi Sakai,Hidetoshi Hayashi,Tsutomu Iwasa,Yoshikazu Hasegawa,Masayuki Takeda,Kazuhiko Nakagawa	2017	11
7	Very Low Birth Weight Monochorionic Diamniotic Twins as a Risk Factor for Symptomatic Patent Ductus Arteriosus Neonatology ·Hiroshi Yamaguchi,Keiko Wada,Miho Nagasawa,Takefumi Kikusui,Hitomi Sakai,Masami Mizobuchi,Seiji Yoshimoto,Hideto Nakao	2016	2
8	Pulmonary administration of phosphoinositide 3-kinase inhibitor is a curative treatment for chronic obstructive pulmonary disease by alveolar regeneration Journal of Controlled Release ·Michiko Horiguchi,Yuki Oiso,Hitomi Sakai,Tomoki Motomura,Chikamasa Yamashita	2015	22
9	Attitudes and practice patterns for maintaining relative dose intensity of chemotherapy in outpatient clinics: results of a Japanese web-based survey BMC Cancer ·Hitomi Sakai,Noriyuki Katsumata,Genmu Kadokura	2015	2
10	Pulmonary administration of integrin-nanoparticles regenerates collapsed alveoli Journal of Controlled Release ·Michiko Horiguchi,Hisako Kojima,Hitomi Sakai,Hiroshi Kubo,Chikamasa Yamashita	2014	17
11	Isolation and partial characterization of a L-rhamnose-binding lectin from the globiferous pedicellariae of the toxopneustid sea urchin, Toxopneustes pileolus International aquatic research. ·Hitomi Sakai,Kozue Edo,Hideyuki Nakagawa,Mitsuko Shinohara,Rie Nishiitsutsuji,Kiyoshi Ohura	2013	5
12	Successful Management of an Extremely Premature Infant with Congenital Candidiasis SHILAP Revista de lepidopterología ·Masami Mizobuchi,Kazumichi Fujioka,Keiko Wada,Hitomi Sakai,Seiji Yoshimoto,Hideto Nakao,Sota Iwatani,Yuko Murakami	2013	2
13	Increased volume of tracheal aspirate fluid predicts the development of bronchopulmonary dysplasia Early Human Development ·Sota Iwatani,Masami Mizobuchi,Satoshi Tanaka,Kei Inomata,Hitomi Sakai,Seiji Yoshimoto,Hideto Nakao	2012	2
14	Effect of hydrocortisone therapy on severe leaky lung syndrome in ventilated preterm infants Pediatrics International ·Masami Mizobuchi,Sota Iwatani,Hitomi Sakai,Seiji Yoshimoto,Hideto Nakao	2012	4
15	A Novel Chemoattractant Lectin, Karatoxin, From the Dorsal Spines of the Small Scorpionfish Hypodytes rubripinnis Journal of Pharmacological Sciences ·Mitsuko Shinohara,Kuniko Nagasaka,Hideyuki Nakagawa,Kozue Edo,Hitomi Sakai,Koji Kato,Futoshi Iwaki,Kiyoshi Ohura,Haruhiko Sakuraba	2010	8
16	Prophylactic indomethacin in extremely premature infants between 23 and 24 weeks gestation Pediatrics International ·Seiji Yoshimoto,Hitomi Sakai,Masaaki Ueda,Mayumi Yoshikata,Masami Mizobuchi,Hideto Nakao	2009	6
17	Possible use of quercetin, an antioxidant, for protection of cells suffering from overload of intracellular Ca2+: A model experiment Life Sciences ·Yoko Sakanashi,Keisuke Oyama,Hiroko Matsui,Toshihisa B. Oyama,Tomohiro M. Oyama,Yumiko Nishimura,Hitomi Sakai,Yasuo Oyama	2008	84
18	Successful treatment of theophylline toxicity by upper gastrointestinal endoscopy Respiratory Medicine ·Sho Saeki,T Shimoda,Hitomi Sakai,Yoshifumi Soejima,Hiroto Matsuse,S Kohno	2003	7
19	Cytotoxic effects of methanol, formaldehyde, and formate on dissociated rat thymocytes: A possibility of aspartame toxicity Cell Biology and Toxicology ·Yasuo Oyama,Hitomi Sakai,Tomohiro Arata,Yoshiro Okano,Norihiko Akaike,Kei Sakai,K. Noda	2002	68
20	Tri-n-butyltin-induced change in cellular level of glutathione in rat thymocytes: a flow cytometric study Toxicology Letters ·Yoshihiko Okada,Yasuo Oyama,Lumi Chikahisa,Masaya Satoh,Kaori Kanemaru,Hitomi Sakai,Katuhiko Noda	2000	32

About Hitomi Sakai

Hitomi Sakai is a scholar working on Pulmonary and Respiratory Medicine, Microbiology and Obstetrics and Gynecology, having authored 50 papers that have together received 1.0k indexed citations. Recurring topics across this work include Neonatal Respiratory Health Research (11 papers), Invertebrate Immune Response Mechanisms (6 papers), Congenital Diaphragmatic Hernia Studies (5 papers), Aquaculture disease management and microbiota (3 papers), Antimicrobial Peptides and Activities (3 papers), Respiratory Support and Mechanisms (3 papers), Congenital Heart Disease Studies (3 papers) and Pregnancy and preeclampsia studies (2 papers). The work is most often cited by research in Biotechnology (132 citations), Drug Discovery (2 citations) and Molecular Biology (485 citations). Hitomi Sakai has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Takeshi Watanabe, Kiichiro Kobori, K Miyashita, M. Uchida, Hironori Tanaka, Takeshi Fujii, Yasuo Oyama, Yuji Sakai, Kyoichi Mizuno and Kyohei Fujita. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact